Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Trauma-Induced Intrusions
NCT03425929Phase 1Completed
- Sponsor
- University Hospital Bonn
- Start
- Jun 2016
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in post-traumatic stress disorder (PTSD) (3 arms), sponsored by University Hospital Bonn. Primary endpoints: Total number of intrusions following the first trauma movie exposure, Total number of intrusions following the second trauma movie exposure and 4 more. Started Jun 2016; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03425929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03425929.